SPZI yields 4651.16% · ABBV yields 3.06%● Live data
📍 SPZI pulled ahead of the other in Year 1
Combined, SPZI + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPZI + ABBV for your $10,000?
Spooz, Inc. is in the process of changing its name to JP 3E Holdings, Inc. JP3E targets 3E industries: energy, eatables and education/real estate. JP3E has two wholly-owned subsidiaries; JP Energy Global, Pte Ltd. and JP Energy Group, LLC. JP Energy Group LLC purpose is buying and selling food such as sugar, chicken paws, multiple agricultural products and other related commodities while acting as principal and owner of the commodities and not merely as a broker. JP3E's business model utilizes vertical chains of supply through which its beneficial commodity transactions are consummated, having in hand significant contracts for the source and off take for each commodity transaction. JP Energy Global focuses on LNG from full cargo trading of LNG to the vertical value chains of LNG obtained from shale gas, the raw material necessary to produce LNG. JP Energy Global is sourcing and supplying competitive LNG to China and Europe in cooperation with its partners based in the Middle East involving countries such as Saudi Arabia, Qatar, Oman, Southeast Asia and Europe. JP3E, within the education sector, has residential amenities and real property located in Franklin Township, Somerset County, New Jersey at 510 Hamilton Avenue with an educational daycare facility located in close proximity to the Brunswick Train Station and the Rutgers University Student Center.
Full SPZI Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.